WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Anticoagulation_Master_CMAP, Net clinical cost (NCC) hasObservation CRF: Death, Time to the first occurrence of stroke hasObservation CRF: Stroke, Liver function test (LFT) hasMeasurementTime Every 3 months within year 1, Primary efficacy endpoints hasOutcomeAssessment Time to the first occurrence of stroke, Composite endpoint hasObservation Thromboembolic events, CRF: Transient ischemic attacks (TIAs) hasMeasurementMethodology Occurrence rate, Composite endpoint hasObservation CRF: Death, Net clinical cost (NCC) hasObservation CRF: Myocardial infarction (MI), Safety endpoints hasObservation CRF: Bleeding Events, Subgroup hasObservation Concomitant medications, Observation or Assessment is used to monitor the state of Physiolgoical Process, Net clinical cost (NCC) hasObservation Cardiac events, Anticoagulant treatment hasEndpoint Primary efficacy endpoints, CRF: Pulmonary embolism (PE) hasMeasurementMethodology Occurrence rate, Primary efficacy endpoints hasOutcomeAssessment Time to the first occurrence of Non-CNS systemic embolism (SEE), Incidence of bleeding events hasObservation CRF: Minor bleeding event, Main concepts (e.g. SEE, Stroke) are denoted by Larger bold font with thicker outline, Primary efficacy endpoints hasOutcomeAssessment Venous thromboembolisms, Composite endpoint hasObservation PK parameters, Net clinical benefit (NCB) hasObservation CRF: Stroke